These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33398037)
1. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion. Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion. Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Ha S; Iqbal NJ; Mita P; Ruoff R; Gerald WL; Lepor H; Taneja SS; Lee P; Melamed J; Garabedian MJ; Logan SK Oncogene; 2013 Aug; 32(34):3992-4000. PubMed ID: 22986532 [TBL] [Abstract][Full Text] [Related]
4. PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins. Santio NM; Vainio V; Hoikkala T; Mung KL; Lång M; Vahakoski R; Zdrojewska J; Coffey ET; Kremneva E; Rainio EM; Koskinen PJ Cell Commun Signal; 2020 Aug; 18(1):121. PubMed ID: 32771000 [TBL] [Abstract][Full Text] [Related]
5. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930 [TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Tu LC; Yan X; Hood L; Lin B Mol Cell Proteomics; 2007 Apr; 6(4):575-88. PubMed ID: 17220478 [TBL] [Abstract][Full Text] [Related]
7. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Kim J; Roh M; Abdulkadir SA BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470 [TBL] [Abstract][Full Text] [Related]
8. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling. Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766 [TBL] [Abstract][Full Text] [Related]
9. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. van der Meer R; Song HY; Park SH; Abdulkadir SA; Roh M Clin Cancer Res; 2014 Jun; 20(12):3211-21. PubMed ID: 24771642 [TBL] [Abstract][Full Text] [Related]
10. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion. Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345 [TBL] [Abstract][Full Text] [Related]
11. PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer. Ruff SE; Vasilyev N; Nudler E; Logan SK; Garabedian MJ Commun Biol; 2021 Oct; 4(1):1221. PubMed ID: 34697370 [TBL] [Abstract][Full Text] [Related]
12. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991 [TBL] [Abstract][Full Text] [Related]
13. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance. Holder SL; Abdulkadir SA Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399 [TBL] [Abstract][Full Text] [Related]
14. Pim1 regulates androgen-dependent survival signaling in prostate cancer cells. van der Poel HG; Zevenhoven J; Bergman AM Urol Int; 2010; 84(2):212-20. PubMed ID: 20215828 [TBL] [Abstract][Full Text] [Related]
16. Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Wang J; Kim J; Roh M; Franco OE; Hayward SW; Wills ML; Abdulkadir SA Oncogene; 2010 Apr; 29(17):2477-87. PubMed ID: 20140016 [TBL] [Abstract][Full Text] [Related]
17. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423 [TBL] [Abstract][Full Text] [Related]
18. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331 [TBL] [Abstract][Full Text] [Related]